Rosebud Biosciences
YC W22 · Active · Growing micro-organs to find new drugs
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 Numerion LabsShared: drug discovery, biotech, developmentActiveAI | AI | Active | YCW15 |
 Parallel BioShared: drug development, drug discovery, biotechActiveAI | AI | Active | YCS21 |
 Harmonic DiscoveryShared: drug discovery, biotech, diseaseActiveAI | AI | Active | YCS21 |
 NanograbShared: drug discovery, biotech, geneActiveAI | AI | Active | YCS23 |
 Output BiosciencesShared: ai-powered drug discovery, biotech, therapeuticActiveAI | AI | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Lavo Life SciencesShared: ai-powered drug discovery, biotechInactiveAI | AI | Inactive | YCW23 |
 Talus BioShared: drug discovery, biotech, targetActiveOther | Other | Active | YCS21 |
 Synkrino BiotherapeuticsShared: ai-powered drug discovery, biotechActiveAI | AI | Active | YCS18 |
 Ångström AIShared: drug development, ai-powered drug discovery, biotechActiveAI | AI | Active | YCS24 |
 Tamarind BioShared: drug discovery, biotechActiveAI | AI | Active | YCW24 |
Also from W22 in AI
All of W22
About Rosebud Biosciences
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.
- YC batch
- W22 · Winter 2022
- Status, per YC
- Active
- Category
- AI
- Team size
- 3
- Location
- San Francisco, CA, USA; San Carlos, CA, USA
- Checked
- 1h ago
YC tags: AI-powered Drug Discovery, Pediatrics, Biotech
Rosebud Biosciences: questions
Which YC batch was Rosebud Biosciences in?
Rosebud Biosciences was in Y Combinator's Winter 2022 batch (W22).
Is Rosebud Biosciences still active?
Y Combinator lists Rosebud Biosciences as active.
Where is Rosebud Biosciences based?
Rosebud Biosciences lists San Francisco, CA, USA; San Carlos, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.